| scholarly article | Q13442814 |
| P356 | DOI | 10.1093/RHEUMATOLOGY/29.1.41 |
| P698 | PubMed publication ID | 1968354 |
| P2093 | author name string | T Gibson | |
| P Jobanputra | |||
| D G Macfarlane | |||
| M M Corkill | |||
| P433 | issue | 1 | |
| P921 | main subject | ankylosing spondylitis | Q52849 |
| P304 | page(s) | 41-45 | |
| P577 | publication date | 1990-02-01 | |
| P1433 | published in | British Journal of Rheumatology | Q27709787 |
| P1476 | title | A controlled trial of sulphasalazine treatment of chronic ankylosing spondylitis: failure to demonstrate a clinical effect | |
| P478 | volume | 29 |
| Q67465264 | Ankylosing spondylitis. Current drug treatment |
| Q36495453 | Are there any antirheumatic drugs that modify the course of ankylosing spondylitis? |
| Q77120985 | Current guidelines for the drug treatment of ankylosing spondylitis |
| Q34536754 | Enteropathic arthritis |
| Q33567171 | Evidence for differential effects of sulphasalazine on systemic and mucosal immunity in rheumatoid arthritis |
| Q71809487 | Fifteen months' follow-up of intensive inpatient physiotherapy and exercise in ankylosing spondylitis |
| Q38071925 | Non-biologic disease-modifying antirheumatic drugs (DMARDs) improve pain in inflammatory arthritis (IA): a systematic literature review of randomized controlled trials. |
| Q39389171 | Oral Anaerobic Bacteria in the Etiology of Ankylosing Spondylitis |
| Q38499216 | Periodontal pathogens are likely to be responsible for the development of ankylosing spondylitis |
| Q36286209 | Pharmacological treatment of ankylosing spondylitis: a systematic review |
| Q37879332 | Prognosis, course of disease, and treatment of the spondyloarthropathies |
| Q39230946 | Second-line treatment in seronegative spondylarthropathies |
| Q24187791 | Sulfasalazine for ankylosing spondylitis |
| Q24244129 | Sulfasalazine for ankylosing spondylitis |
| Q37614364 | The use of sulphasalazine as a disease modifying antirheumatic drug |
Search more.